Tencent-Linked Health AI Developer Raises $25 Million
This article is for subscribers only.
Medopad Ltd., a U.K. artificial intelligence startup teaming with China’s Tencent Holdings Ltd. on new approaches to disease, raised $25 million for clinical studies of its health technology.
Leaps by Bayer, an investment arm of Bayer AG, led the series B round, Medopad said in a statement. The London-based firm is focused on finding and using digital indicators of illness to guide treatment of conditions like Alzheimer’s disease and diabetes.